Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 May 1;84(1):70–77. doi: 10.1097/QAI.0000000000002294

Figure 1:

Figure 1:

Raltegravir concentrations for raltegravir-naïve cohort 2 infants plotted against collection time. Plasma concentration vs. time points for each infant are represented with a different color. Dotted line represents trough concentration target of 33 ng/mL. Concentrations below the lower limit of quantitation (10 ng/mL) are plotted at 5 ng/mL.